MUC16 and ovarian cancer: Therefore, the primary objective of this study was to perform a head-to-head comparison between a novel chemiluminescence-based exosomal ovarian cancer auxiliary diagnostic kit (OCS) and the conventional serum CA125 test, to evaluate whether this new technology offers superior sensitivity and specificity for diagnosing EOC.